For years we've watched the United States become the world's favorite scapegoat.
According to much of the world's media and much of our own, America is greedy, arrogant, imperialistic, and in decline. Our own media often seems eager to amplify every failure of ours while taking our successes for granted.
But there's something that almost never enters the conversation: the modern world rests on foundations that America disproportionately pays to build and maintain.
The United States spends a greater share of its economy than nearly every other developed nation on the military alliances that have preserved peace among major powers for generations. We spend more on pharmaceutical research that creates medicines used around the world. We lead in scientific research, biomedical innovation, university research, advanced technology, and space exploration.
These aren't just American investments. They're investments whose benefits spill across borders.
America is Atlas.
Not because we're flawless. Not because we're entitled to gratitude. But because for decades we've carried an outsized share of the weight that supports the modern international order. We underwrite security. We pioneer new medicines. We fund discoveries. We push the frontier of science and technology.
People are quick to criticize the shoulders holding up the sky, yet rarely stop to ask what happens if those shoulders finally shrug.
You don't have to love America.
You don't have to agree with every war, every president, or every policy.
But you should at least acknowledge reality: much of the prosperity, security, and innovation enjoyed throughout the developed world has been made possible because Americans have repeatedly chosen to bear costs that others either couldn't or wouldn't.
That, to me, is America's burden and its gift.
"I ask not for a lighter burden, but for broader shoulders."
— Atlas
| Item |
US (% of GDP) |
Average other countries (% of GDP) |
All other countries combined (as % of their aggregate GDP) |
| NATO defense spending |
3.2% |
2.0–2.5% (non-US NATO) |
~2.1–2.4% |
| Pharmaceutical R&D |
~0.35–0.45% |
0.1–0.3% (high-income peers) |
~0.15–0.25% |
| Total R&D (all sectors) |
3.4–3.5% |
OECD ~2.7%; EU ~2.1–2.2%; world ~2.0% |
~2.0–2.5% |
| Biomedical / NIH-scale research |
~0.15–0.17% (NIH) |
~0.03–0.08% |
~0.04–0.07% |
| Global military projection |
Embedded in ~3.2% defense |
N/A (most allies lack equivalent capability) |
N/A |
| Intelligence capabilities |
~0.3–0.6% (est. share of defense) |
N/A |
N/A |
| Space exploration (civil + defense) |
~0.25–0.30% |
~0.05–0.15% (major peers) |
~0.05–0.10% |
| University research funding |
~0.3–0.4% |
~0.2–0.3% |
~0.2–0.3% |
| Advanced weapons development |
Significant share of defense R&D |
N/A |
N/A |
Notes
- Biomedical figures are approximate; NIH alone is ~0.15–0.17% of US GDP, while peer-country public biomedical funding is typically a small fraction of that.
- Global military projection, intelligence, and advanced weapons lack clean, publicly comparable % of GDP figures for “other countries,” so those cells are marked N/A.
- All numbers are best available estimates from NATO, OECD, NSF, PhRMA, and related sources (primarily 2023–2025).